CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 512 enrolled
Drug / intervention
LungTalk +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05824273
NCT05824273N/ACompleted
CompareCT.gov

Leveraging Social Media to Increase Lung Cancer Screening Awareness, Knowledge and Uptake in High-Risk Populations

Hackensack Meridian Health·interventional·Posted Apr 21, 2023·Updated Nov 21, 2025

In Brief

A clinical study evaluating LungTalk and Non-tailored intervention - Standard of practice for Lung Cancer. Completed, enrolled 512 participants across 1 site.

Detailed Summary

LungTalk and leveraging Facebook-targeted Advertisement (FBTA) addresses the call to develop and test multi-level, cancer communication interventions using innovative methods and designs. The study's long term goal is to increase lung cancer screening uptake among appropriate, high-risk individuals nationwide.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLung Cancer
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI)

Timeline

N/ACompletedFinished
202420252026
First PostedApr 21, 2023
Enrollment StartAug 2, 2023
Primary CompletionJul 30, 2024
TodayJul 2, 2026
Enrollment to primary: 12 monthsPosted 3.2 years ago

Interventions

LungTalkbehavioral

LungTalk is a 10-15 minute long computer-tailored health communication and decision-making tool.

Non-tailored intervention - Standard of practicebehavioral

ACS Lung Screening Informational Video